AI-generated summary
In this randomized, placebo-controlled study in rats with metabolic syndrome-related kidney disease, the authors report that low-level laser therapy was associated with lower blood pressure, better preserved glomerular filtration rate and less interstitial fibrosis compared with sham treatment. The authors describe this as an initial proof-of-concept study that should be further evaluated.
- Who or what was studied
- Rats (ZSF1 strain) with nephropathy, hypertension, hyperlipidemia and type II diabetes
- Limits stated in the abstract
- The abstract describes an initial proof-of-concept study in animals, and the authors state that the findings should be further evaluated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation, Placebo-controlled, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.